GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network | Nature Communications
ZNF503/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression. - Abstract - Europe PMC
IJMS | Free Full-Text | Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer
GATA-3 – Zeta Corporation
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver | bioRxiv
GATA3 (MSVA-450M) - MS Validated Antibodies
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
Clinicopathological analysis of GATA3-positive breast cancers with special reference to response to neoadjuvant chemotherapy - ScienceDirect
Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance | BMC Cancer | Full Text
Pathology Outlines - GATA3
Q&A column - CAP TODAY
Expression of GATA3 in breast cancer cells before and after... | Download Scientific Diagram
Diagnostics | Free Full-Text | GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature
The role of GATA3 in breast carcinomas: a review - ScienceDirect
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers | bioRxiv
Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß | PLOS ONE
Pathology Outlines - GATA3
14-3-3τ drives estrogen receptor loss via ERα36 induction and GATA3 inhibition in breast cancer | PNAS
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression. - Abstract - Europe PMC
Comparison of GATA-3, mammaglobin, GCDFP-15 expression in breast carcinoma in serous effusions: A cell-block micro-array study
Anti-GATA-3 Monoclonal Antibody(Clone: GATA3/2444)
GATA-3 Antibody - Biocare Medical
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers | Communications Biology
The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver | Oncogene
GATA3 knock-down analysis in MCF7 and T47D breast cancer cell lines.... | Download Scientific Diagram
